ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: TH-OR12

The Calcified Vasculature in CKD Secretes Signal Proteins That Inhibit Bone Mineralization

Session Information

Category: Bone and Mineral Metabolism

  • 401 Bone and Mineral Metabolism: Basic

Authors

  • Mace, Maria Lerche, Rigshospitalet, Copenhagen, Denmark
  • Gravesen, Eva, Dept of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
  • Egstrand, Søren, Rigshospitalet, Copenhagen, Denmark
  • Nordholm, Anders, Rigshospitalet, Copenhagen, Denmark
  • Morevati, Marya, Rigshospitalet, Copenhagen, Denmark
  • Olgaard, Klaus, Rigshospitalet, Copenhagen, Denmark
  • Lewin, Ewa, Rigshospitalet, Copenhagen, Denmark
Background

Our group has recently demonstrated that CKD-induced vascular calcification impairs bone formation & mineralization in an in vivo model by transplanting calcified aortas from CKD rats into healthy recipients. Aim was to confirm our hypothesis of a direct crosstalk between the vasculature & bone in in vitro experiments.

Methods

Vascular calcification was induced in uremic Wistar rats. Normal aortas (NA) & uremic calcified aortas (CA) were incubated ex vivo or co-incubated with UMR-106 cell line (UMR). Media was measured for Wnt inhibitors sclerostin (Scl), Dkk1, SFRP4 & activin A (Act A). UMR-106 cell mineralization stained with Alizarin red. Signal pathways were analyzed by PCR and WB.

Results

CA completely inhibited mineralization in UMR-106 cells (Figure 1). Mineralization inhibitor osteopontin (OPN) mRNA & protein were highly upregulated in UMR+CA (OPN mRNA UMR+CA 25.50 [5.53-51.00], UMR+NA 2.78 [1.20-7.85], UMR 0.80 [0.39-5.49], p<0.001). Induction of OPN was abolished by LiCl. ANKH was upregulated in UMR+UA (2.95 [1.87-7.32], UMR+NA 1.75 [0.51-2.46], UMR 0.96 [0.49-2.15], p<0.01), whereas same levels of Alpl were found. Similar expressions of β-catenin protein & Wnt target genes c-Myc & Ccnd1 were found. However, Jun was upregulated in UMR+NA & UMR+CA (UMR 0.94 [0.61-2.83] vs. UMR+NA 1.58 [1.18-2.29] vs. UMR+CA 1.98 [1.08-3.44], p< 0.01). The CA secreted large amounts of Scl (1936 [495-4400] vs. NA 31 [7-88] pg/ml, p=0.002), Dkk1 (353 [110-686] pg/ml vs. none in NA), and Act A (12158 [4712-18000] vs. NA 1838 [250-4146] pg/ml, p=0.002). NA & CA secreted SFRP4.

Conclusion

The present study confirms our hypothesis on a direct crosstalk between vasculature and bone. The uremic calcified aorta secretes signal molecules that inhibit bone mineralization .

Funding

  • Private Foundation Support